Matthias Voigt

Matthias Voigt is a seasoned professional in the field of biomedical chemistry and pharmacy, currently serving as Director of Late-Stage Formulation Process Development at BioNTech SE since January 2020, following roles as Senior Scientist and Scientist. His expertise encompasses late-stage formulation process development, commercialization, and individualized vaccines. Prior experience includes serving as a Graduate Research Associate at the Collaborative Research Center 1066 from May 2014 to January 2020, focusing on developing multifunctional nanoparticular drug carriers for melanoma immunotherapy, as well as at Johannes Gutenberg-Universität Mainz from March 2015 to December 2019, where the development of screening methods for liposomal systems was emphasized. Matthias Voigt holds a PhD in Biomedical Chemistry and Pharmacy and a master’s equivalent degree in the same field from Johannes Gutenberg University Mainz, supplemented by studies at the University of Aberdeen.